Filter by collection

Current filters:


Current filters:


Refine By:

Search Results

Results 1-10 of 22 (Search time: 0.121 seconds).
Item hits:
  • BB


  • Authors: AbdelMassih, Antoine;  Advisor: -;  Participants: Sedky, Abrar; Shalaby, Ahmed; Shalaby, AlAmira-Fawzia; Yasser, Alia; Mohyeldin, Aya; Amin, Basma; Saleheen, Basma; Osman, Dina; Samuel, Elaria; Abdelfatah, Emmy; Albustami, Eveen; ElGhamry, Farida; Khaled, Habiba; Amr, Hana; Gaber, Hanya; Makhlouf, Ismail; Abdeldayem, Janna; El-Beialy, Jana Waleed; Milad, Karim; Sharkawi, Laila El; Abosenna, Lina; Safi, Madonna G.; AbdelKareem, Mariam; Shershaby, Meryam El (2022)

  • After the discovery of the SARS-CoV-2 variant, Omicron, that sporadically arose in November 2021, it was compared to the Delta variant that was discovered in May 2021 in terms of virulence and transmissibility. While Omicron has shown higher rates of transmission than the other variants, it showed less virulent symptoms with relatively mild disease. The Delta variant, however, has been associated with high virulence causing severe lower respiratory tract symptoms and reduced transmission rate (Kumar et al. 2021). This leaves us wondering; does COVID-19 agree with the trade-off hypothesis?

  • BB


  • Authors: Alkattan, Abdullah;  Advisor: -;  Participants: Radwan, Nashwa; Mahmoud, Nagla; Alkhalifah, Ahmed; Alshamlan, Ammar; Alkamis, Abdullah; Alfaifi, Amal; Alanazi, Wedad; Alfaleh, Amjad; Haji, Alhan; Alabdulkareem, Khaled (2022)

  • A cross-sectional study was conducted from August 2021 to January 2022 in Saudi Arabia. The study included 281 residents to estimate their acceptance to receive COVID-19 vaccination. Around 70% of the included participants had a moderate to high COVID-19 vaccine acceptance rate during the data collection period. The risk increases to about two folds among undergraduates, and increases to four folds among non-employed, About 78% of participants with high and 44% with low COVID-19 vaccine acceptance believed the vaccines were safe and effective. The belief that COVID-19 disease will be controlled within two years increased the risk for low vaccine acceptance by about two folds Good knowledge about COVID-19 vaccination significantly affected the acceptance rate

  • BB


  • Authors: S. Amoo, Olufemi;  Advisor: -;  Participants: Onyia, Ngozi; I. Onuigbo, Tochukwu; U. Vitalis, Stephanie; Davies-Bolorunduro, Olabisi F.; Joy I. Oraegbu; Adeniji, Esther T.; Obi, Josephine C.; Abodunrin, Olusola N.; Ikemefuna, Amaka S.; Adegbola, Richard A.; Audu, Rosemary A.; Salako, Babatunde L. (2022)

  • Social and demographic characteristics of study participants The descriptive statistics for all the patients with COVID-19 were summarized and are presented in Table 2. Among the 236 participants, 158 (66.9%) were males and 78 (33.1%) were females. The mean ± SD age of the SCP was 52.3 ± 16.9 years and 42.4 ± 17.2 years for the NSCP. Most of the participants were between 24 and 65 years of age.

  • BB


  • Authors: Muhammad, Yasin Ali;  Advisor: -;  Participants: - (2022)

  • At the time of this writing, SARS-CoV-2 has reportedly claimed the lives of millions of people worldwide. However, there is still disagreement concerning the origin of SARS-CoV-2, its true nature, and the extent of its pathogenicity. Thus, the purpose of this manuscript is to highlight and critically analyze these differences so that research efforts can be geared toward addressing these concerns.

  • BB


  • Authors: Choudhury, Priyanka Ray;  Advisor: -;  Participants: Saha, Tapoja; Goel, Sachin; Shah, Janvi Manish; Ganjewala, Deepak (2022)

  • The majority of pandemics are known to be a result of either bacteria or viruses out of which viruses seem to be an entity of growing concern due to the sheer number of yet unidentified and potentially threatening viruses, their ability to quickly evolve and transform, their ability to transfer and change from one host organism to another and the difficulty in creating safe vaccines on time.

  • BB


  • Authors: Muche, Meseret;  Advisor: -;  Participants: Yemata, Getahun; Molla, Eyayu; Muasya, A. Muthama; Tsegay, Berhanu Abraha (2022)

  • The Coronavirus (COVID-19) is a global pandemic caused by SARS-CoV-2, which has an enormous effect on human lives and the global environment. This review aimed to assess the global scientific evidence on the impact of COVID-19 lockdown on natural resources using international databases and search engines. Thus, the unprecedented anthropause due to COVID-19 has positive and negative effects on natural resources.

  • BB


  • Authors: Rahul Gupta;  Advisor: -;  Participants: - (2022)

  • The hyperinflammatory state leading to an aberrant cytokine production, culminating in acute respiratory distress syndrome, sepsis and multi-organ dysfunction contribute much to the pathophysiologies of severe COVID-19. These severe patients have similar clinical manifestations with patients suffering from certain auto-inflammatory disorders and cytokine storm syndromes. Interestingly, anakinra (blocking both IL-1α and IL-1β) has shown promises in treating these patients with hyperinflammatory disorders, sepsis with multiorgan failures. Another inflammasome, AIM2, involved in production of IL-1 has also been found to be implicated in COVID-19. IL-1β, a known procoagulant, causes induction of tissue factor with increasing vascular endothelial permeability loss ensuing in hypercoagula...

  • BB


  • Authors: Giri, Simran;  Advisor: -;  Participants: Sen, Sanjukta; Singh, Rohan; Paul, Paramita; Sahu, Ranabir; Nandi, Gouranga; Dua, Tarun Kumar (2022)

  • The World Health Organization declared the outbreak of the novel coronavirus (COVID-19) as a global health emergency on January 30, 2020, and as a pandemic disease on March 11, 2020. This review highlights the international situation, risk factors, and related protections to be taken as prerequisite measures and probable treatment options for the COVID-19-infected population in the current scenario.

  • BB


  • Authors: Suri, Arpita;  Advisor: -;  Participants: Singh, Naveen Kumar; Perumal, Vanamail (2022)

  • COVID-19 outbreak has engulfed different parts of the world, affecting more than 163 million people and causing more than 3 million deaths worldwide due to human transmission. Thus, it has become critical to identify the risk factors and laboratory parameters to identify patients who have high chances of worsening clinical symptoms or poor clinical outcomes. Therefore, the study aims to identify inflammatory markers that can help identify patients at increased risk for progression to critical illness, thus decreasing the risk of any mortality. Our study focussed on the predictive utility of C-reactive protein, Interleukin-6, D-dimer and Procalcitonin in assisting the management of COVID-19 patients with adverse clinical effects. Through literature search in electronic databases, we ...